1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

Intronix Technologies Obtains FDA 510(k) Clearance for Myoguide™ System

Intronix wins US regulatory clearance for its Myoguide device with assistance from Emergo Group

 
Emergo Group linear logo
Emergo Group linear logo
PRLog - Jan. 30, 2012 - AUSTIN, Texas -- Intronix Technologies Corporation, a Bolton, Ontario-based medical technology developer, has been granted 510(k) clearance by the US Food and Drug Administration (FDA) for its Myoguide injection site targeting system.

A hand-held, battery-operated device, Myoguide functions by amplifying electrical activity generated by patients’ muscles and providing audio feedback to clinicians to more effectively locate areas of muscle activity and better select injection sites. The device can help in treatments such as pain management, movement disorder treatment and cosmetic procedures.

Intronix’s FDA 510(k) application process was supported by Emergo Group, a medical device regulatory consulting firm headquartered in Austin, Texas.  Dr. Evan Friedman, President at Intronix, explains the process of selecting third-party assistance to navigate the 510(k) process.

“As this was our first FDA 510(k), we were looking for a company that had knowledge dealing with the FDA and could also serve as our regulatory representative in Europe  and the US,” says Friedman. “Emergo Group was a great fit for us because we plan to expand into other international markets in the future and they have offices in all the markets we plan to enter.”

Once Intronix partnered with Emergo Group, the consulting firm prepared all 510(k) application materials based on the manufacturer’s technical information. Then Intronix reviewed and edited the application prior to submission to the FDA.

“For companies such as Intronix going through the FDA 510(k) process for the first time, the process can often prove more complex and challenging than in other markets,” says Richard Vincins, Vice President of Quality Assurance Consulting at Emergo Group. “By leveraging our regulatory expertise to win FDA clearance, Intronix can focus on product development and marketing in the US.”

About Intronix
Intronix has been manufacturing medical devices since 1984 and specializes in electrophysiological amplifiers for use in the study of the electrical activity of muscles. More information at intronix.com

About Emergo Group
Emergo Group is a global medical device regulatory consulting firm providing a wide range of services for device registration, QMS compliance, clinical trial management, in-country representation, reimbursement and distributor search consulting.

Additional Information
Intronix Technologies Corporation
26 McEwan Drive West, Unit 15
Bolton, Ontario L7E 1E6
info@intronixtech.com
+1 905 951 3361

Photo:
http://www.prlog.org/11785426/1

--- End ---

Click to Share

Contact Email:
***@emergogroup.com Email Verified
Source:Emergo Group
Phone:512-327-9997
Zip:78701
City/Town:Austin - Texas - United States
Industry:Medical, Health, Science
Tags:fda, Intronix, emergo group, Myoguide, medical device
Shortcut:prlog.org/11785426
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share